News


June 26, 2017

Multiple myeloma treatment advances: What health execs should know

Multiple myeloma is a rare cancer, representing about 1.8% of all cancers combined, according to the National Cancer Institute. About 30,000 new cases are expected in the U.S. in 2017. It is more common in men than women, among individuals of African-American descent, and those aged 65 years and older. The SEER Cancer Statistics Review,…


June 16, 2017

My First Big Dam Post

Gareth Morgan, MD, FRCP, FRCPath, Ph.D.

So, first I would like to say that bicycling is a great joy in my life, but I find that I really cannot tell you that.  I am aging, and it is killing my body.  Nonetheless, let’s get this blog thing going. Besides being a middle-aged Welsh myeloma doctor from London, now living for almost…


April 18, 2017

Honors for Man & Woman for fighting blood cancer

Nadine Baxter, president of the Leukemia & Lymphoma Society board, lost her mother to acute myeloblastic leukemia within three days of her diagnosis in 2013. Baxter is gearing up for the society’s Man & Woman of the Year Grand Finale Celebration, to be held Friday.

Nadine Baxter has spent the last 17 of her 40 years as a nurse practitioner working with blood-cancer patients, specifically those with myeloma. Four years ago, blood cancer hit home. Hard and fast. “My mother developed a cough, and we didn’t know what the problem was,” Baxter recalls. She took her to a pulmonologist, and…


April 5, 2017

The Myeloma Genome Project with Dr. Gareth Morgan, UAMS Myeloma Institute

Dr. Gareth Morgan

Clues to be found in more personalized treatment for multiple myeloma can be found in the genetics of myeloma in each individual patient. Dr. Gareth Morgan and the UAMS Myeloma Institute in collaboration with the Dana Farber Cancer Institute and other institutions are working to collect genomic data from myeloma patients with the goal of…


March 30, 2017

Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment

Nonsecretory Multiple Myeloma

Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention. However, there is a subset of multiple myeloma patients who do not secrete immunoglobulin or its component parts into either the blood or urine, hence called non-secretory myeloma. Some non-secretory myeloma patients…


March 21, 2017

Faces of UAMS: Brian Walker, Ph.D.

Meet Brian Walker, Ph.D. Brian Walker is the director of research for the UAMS Myeloma Institute.

Brian Walker is the director of research for the UAMS Myeloma Institute. March is Multiple Myeloma Awareness Month, and Walker discusses what that special focus on myeloma means, his research and how the UAMS Myeloma Institute’s world-leading status for the research and treatment of it drew him to accept his position here more than a…


Understanding Multiple Myeloma: Dr. Faith Davis from UAMS

UAMS Myeloma Institute's Dr. Faith Davies joined THV11 This Morning today to raise awareness about multiple myeloma, its causes and treatments.

March 7, 2017

Dr. Frits Van Rhee with UAMS joins Fox 16 Good Day

Myeloma awareness

Dr. Frits Van Rhee with UAMS joins Fox 16 Good Day to tell us more about multiple myeloma and how it’s treated. Watch video below: http://www.fox16.com/klrt-good-day/myeloma-awareness-month/667936670  


March 2, 2017

U.S. Ambassador Chooses UAMS Myeloma Institute

U.S. Ambassador Chooses UAMS Myeloma Institute

March 2, 2017 | Ambassador Ruth A. Davis traveled the world as a U.S. diplomat during her 40 years with the U.S. Foreign Service. But when she learned she had a relapse of multiple myeloma, a cancer of plasma cells in the blood, she headed to Arkansas and the UAMS Myeloma Institute. “I’ve often had…


March 1, 2017

March 2017 DAISY Award

Congratulations to Melissa Thomas, RN III for being selected as the DAISY Award recipient for the month of March!

Melissa Thomas, RN III – The Myeloma Institute Congratulations to Melissa Thomas, RN III for being selected as the DAISY Award recipient for the month of March! Melissa works in The Myeloma Institute and was nominated by a co-worker who was also a patient.  The nomination below reflects how Melissa impacted her life in a…



Previous page Next page